logo of Angiochem
Portfolio company

Angiochem Inc.

Details
Region
Quebec
Industry sector
Drugs
Investment year
2005
Fund
Healthcare Venture Fund
Learn More
Our partnership

AngioChem is a BDC Capital Healthcare Venture Fund company, co-managed in partnership by Amplitude Venture Capital.

Contact

Bharat Srinivasa, Principal at Amplitude Venture Capital

About the company

Angiochem is a clinical-stage biotechnology company discovering and developing new breakthrough drugs that are leveraging the LRP-1 mediated pathway to cross the blood-brain barrier (BBB) to treat brain diseases.